A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder

Neuropsychobiology

Volumn 67, Issue 4, 2013, Pages 224-229

  Strawn, Jeffrey R ^a   Chu, Wen Jang ^a   Whitsel, Rachel M ^a   Weber, Wade A ^a   Norris, Matthew M ^a   Adler, Caleb M ^a   Eliassen, James C ^a   Phan, K Luan ^b,c   Strakowski, Stephen M ^a   Delbello, Melissa P ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Anterior cingulate cortex; Generalized anxiety disorder; Glutamate

Indexed keywords

CREATINE; GLUTAMIC ACID; INOSITOL; N ACETYLASPARTIC ACID;

ADOLESCENT; ADOLESCENT DISEASE; AMINO ACID BLOOD LEVEL; ANTERIOR CINGULATE; ANXIETY; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HUMAN; MALE; NEUROCHEMISTRY; NEUROPATHOLOGY; PEDIATRIC ANXIETY RATING SCALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGICAL RATING SCALE; SCHOOL CHILD; BRAIN LEVEL; PILOT STUDY; SYMPTOMATOLOGY;

ADOLESCENT; ANXIETY DISORDERS; ASPARTIC ACID; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CHILD; CREATINE; FEMALE; GLUTAMIC ACID; GYRUS CINGULI; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PILOT PROJECTS;

EID: 84876794422     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000347090     Document Type: Article

References (46)

1. Ialongo N, Edelsohn G, Werthamer-Larsson L, Crockett L, Kellam S: The significance of self-reported anxious symptoms in firstgrade children. J Abnorm Child Psychol 1994; 22: 441-455.
2. Ialongo N, Edelsohn G, Werthamer-Larsson L, Crockett L, Kellam S: The significance of self-reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade. J Child Psychol Psychiatry 1995; 36: 427-437.
3. Foley DL, Goldston DB, Costello EJ, Angold A: Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. Arch Gen Psychiatry 2006; 63: 1017-1024.
4. Jacobson CM, Muehlenkamp JJ, Miller AL, Turner JB: Psychiatric impairment among adolescents engaging in different types of deliberate self-harm. J Clin Child Adolesc Psychol 2008; 37: 363-375.
5. Pine DS, Cohen P, Gurley D, Brook J, Ma Y: The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998; 55: 56-64.
6. Bittner A, Goodwin RD, Wittchen HU, Beesdo K, Hofler M, Lieb R: What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 2004; 65: 618-626.
7. Beesdo K, Knappe S, Pine DS: Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am 2009; 32: 483-524.
8. Beesdo K, Pine DS, Lieb R, Wittchen HU: Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67: 47-57.
9. Strawn JR, Wehry AM, DelBello MP, Rynn MA, Strakowski SM: Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. Depress Anxiety 2012; 29: 328-339.
10. Beesdo K, Lau JYF, Guyer AE, McClure-Tone EB, Monk CS, Nelson EE, Fromm SJ, Goldwin BA, Wittchen H-U, Leibenluft E, Ernst M, Pine DS: Common and distinct amygdalafunction perturbations in depressed versus anxious adolescents. Arch Gen Psychiatry 2009; 66: 275-285.
11. Monk CS, Nelson EE, McClure EB, Mogg K, Bradley BP, Leibenluft E, Blair RJ, Chen G, Charney DS, Ernst M, Pine DS: Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry 2006; 163: 1091-1097.
12. McClure EB, Monk CS, Nelson EE, Parrish JM, Adler A, Blair RJ, Fromm S, Charney DS, Leibenluft E, Ernst M, Pine DS: Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder. Arch Gen Psychiatry 2007; 64: 97-106.
13. Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HM, Chen G, McClure-Tone EB, Ernst M, Pine DS: Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry 2008; 65: 568-576.
14. Strawn JR, Bitter SM, Adler CM, Chu W, Eliassen JC, Whitsel R, Weber WA, Cerullo MA, Strakowski SM, DelBello MP: Neurocircuitry of generalized anxiety disorder in adolescents: a pilot functional magnetic resonance and functional connectivity study. Depress Anxiety 2012; 29: 939-947.
15. Cerullo MA, Adler CM, DelBello MP, Strakowski SM: The functional neuroanatomy of bipolar disorder. Int Rev Psychiatry 2009; 21: 314-322.
16. Strakowski SM, Eliassen JC, Lamy M, Cerullo MA, Allendorfer JB, Madore M, Lee JH, Welge JA, DelBello MP, Fleck DE, Adler CM: Functional magnetic resonance imaging brain activation in bipolar mania: evidence for disruption of the ventrolateral prefrontalamygdala emotional pathway. Biol Psychiatry 2011; 69: 381-388.
17. Etkin A, Egner T, Kalisch R: Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci 2011; 15: 85-93.
18. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P: The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann NY Acad Sci 2001; 935: 107-117.
19. Yamasaki H, LaBar KS, McCarthy G: Dissociable prefrontal brain systems for attention and emotion. Proc Natl Acad Sci USA 2002; 99: 11447-11451.
20. Phan KL, Fitzgerald DA, Cortese BM, Seraji-Bozorgzad N, Tancer ME, Moore GJ: Anterior cingulate neurochemistry in social anxiety disorder: 1 H MRS at 4 Tesla. Neuroreport 2005; 16: 183-186.
21. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ: Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 2004; 43: 1146-1153.
22. Yüksel C, Öngür D: Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 2010; 68: 785-794.
23. Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, Velakoulis D, Pantelis C: Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust NZ J Psychiatry 2008; 42: 467-477.
24. Strawn JR, Patel NC, Chu W-J, Lee JH, Adler CM, Kim MJ, Bryan H, Alfieri DC, Welge JA, Blom TJ, Nandagopal JJ, Strakowski SM, Del-Bello MP: Glutamatergic effects of divalproex in manic adolescents: a proton magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry 2012; 51: 642-651.
25. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS: A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 2006; 146: 137-147.
26. Gasparovic C, Yeo R, Mannell M, Ling J, Elgie R, Phillips J, Doezema D, Mayer AR: Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1 Hmagnetic resonance spectroscopy study. J Neurotrauma 2009; 26: 1635-1643.
27. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, Soutullo C: Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 2001; 40: 450-455.
28. Andreasen NC, Endicott J, Spitzer RL, Winokur G: The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 1977; 34: 1229-1235.
29. Crovitz HF, Zener K: A group-test for assessing hand-and eye-dominance. Am J Psychol 1962; 75: 271-276.
30. Duke PM, Litt IF, Gross RT: Adolescents' selfassessment of sexual maturation. Pediatrics 1980; 66: 918-920.
31. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002; 41: 1061-1069.
32. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
33. Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R: Preliminary studies of the reliability and validity of the Children's Depression Rating Scale. J Am Acad Child Adolesc Psychiatry 1984; 23: 191-197.
34. Lee J-H, Garwood M, Menon R, Adriany G, Andersen P, Truwit CL, Ugurbil K: High contrast and fast three-dimensional magnetic resonance imaging at high fields. Magn Reson Med 1995; 34: 308-312.
35. Gruetter R, Boesch C: Fast, noniterative shimming of spatially localized signals. In vivo analysis of the magnetic field along axes. J Magn Reson 1992; 96: 323-334.
36. Tkac I, Staruck Z, Choi IY, Gruetter R: In vivo H NMR spectroscopy of rat brain at 1ms echo time. Magn Reson Med 1999; 41: 649-656.
37. Provincher SW: Estimation of metabolite concentration from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
38. Grachev ID, Apkarian AV: Anxiety in healthy humans is associated with orbital frontal chemistry. Mol Psychiatry 2000; 5: 482-488.
39. Bedard MJ, Chatal S: Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression. Psychiatry Res 2011; 192: 45-54.
40. Walker DL, Rattiner LM, Davis M: Group II metabotropic Glu receptors within the amygdala regulate fear as assessed with potentiated startle in rats. Behav Neurosci 2002; 116: 1075-1083.
41. Fontanez-Nuin DE, Santini E, Quirk GJ, Porter JT: Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons. Cereb Cortex 2011; 21: 727-735.
42. Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ: Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic Glu receptors. J Pharmacol Exp Ther 1998; 284: 651-660.
43. Shekhar A, Keim SR: LY354740, a potent group II metabotropic Glu receptor agonist prevents lactate-induced panic-like response in panic-prone rats. Neuropharmacology 2000; 39: 1139-1146.
44. Strawn JR, Sakolsky DJ, Rynn MA: Psychopharmacologic treatment of anxiety disorders in children and adolescents. Child Adolesc Psychiatr Clin N Am 2012; 21: 527-539.
45. Sakolsky D, Nurmi E, Birmaher B, March J, Walkup J, Piacentini J, Kendall P, Albano AM, Compton S, Sherill J, Rynn M, Ginsburg G, Badashova K, McCracken J: Association of GRIK4 with treatment response in the Child/Adolescent Anxiety Multimodal Study (CAMS). Am Acad Child Adolesc Psychiatry Annu Meet, Toronto, 2011.
46. Dunayevich E, Erickson J, Levine L, Landbloom R, Schoepp DD, Tollefson GD: Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder. Neuropsychopharmacology 2008; 33: 1603-1610.